[Pharmacological studies of N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F-1). 2. General pharmacology].
D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D001241:Aspirin / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010276:Parasympatholytics; D010653:Phenylbutazone / Q000494:pharmacology; D010655:Phenylenediamines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012890:Sleep / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D001565:Benzoates; D010276:Parasympatholytics; D010655:Phenylenediamines; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D010653:Phenylbutazone; D001241:Aspirin